The global Healthcare and Biotechnology market is evolving at the intersection of innovation and regulatory challenges. Technological and healthcare transformations continuously reshape the strategies of key players—laboratories, research centers, and pharmaceutical companies—amid growing demands for responsibility and performance.

In this complex and dynamic environment, our firm provides advisory and litigation support to safeguard value creation throughout the lifecycle of healthcare and biotechnology products and services.

We assist major corporations and start-ups in the medical field with corporate transactions, commercial development projects, and disputes.

• Advised the partners of Healthmark Industries on the sale of shares to the Swedish company Getinge, specifically addressing French legal aspects and matters related to its subsidiary, LTA MEDICAL.
• Advised Theremia, a technology company in the pharmaceutical sector, on all transactional aspects of its fundraising, led by Eurazeo and Salica.
• Defended the co-founder of a biotech company following the sale of 52% of their shares, particularly concerning the interpretation of a good-leaver clause.
• Advised a pharmaceutical laboratory on the acquisition of several targets and the related competition law implications (merger control).
• Advised a publicly listed pharmaceutical company on matters related to financial communication.
• Advised Kreos Capital in tranche-based financing, totaling €150 million, for Abivax.